These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15912508)

  • 1. Differential proteome analysis of conditioned media to detect Smad4 regulated secreted biomarkers in colon cancer.
    Volmer MW; Stühler K; Zapatka M; Schöneck A; Klein-Scory S; Schmiegel W; Meyer HE; Schwarte-Waldhoff I
    Proteomics; 2005 Jul; 5(10):2587-601. PubMed ID: 15912508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells.
    Müller N; Reinacher-Schick A; Baldus S; van Hengel J; Berx G; Baar A; van Roy F; Schmiegel W; Schwarte-Waldhoff I
    Oncogene; 2002 Sep; 21(39):6049-58. PubMed ID: 12203117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomas.
    Reinacher-Schick A; Baldus SE; Romdhana B; Landsberg S; Zapatka M; Mönig SP; Hölscher AH; Dienes HP; Schmiegel W; Schwarte-Waldhoff I
    J Pathol; 2004 Apr; 202(4):412-20. PubMed ID: 15095268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basement membrane component laminin-5 is a target of the tumor suppressor Smad4.
    Zapatka M; Zboralski D; Radacz Y; Böckmann M; Arnold C; Schöneck A; Hoppe S; Tannapfel A; Schmiegel W; Simon-Assmann P; Schwarte-Waldhoff I
    Oncogene; 2007 Mar; 26(10):1417-27. PubMed ID: 16953227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor Smad4 mediates downregulation of the anti-adhesive invasion-promoting matricellular protein SPARC: Landscaping activity of Smad4 as revealed by a "secretome" analysis.
    Volmer MW; Radacz Y; Hahn SA; Klein-Scory S; Stühler K; Zapatka M; Schmiegel W; Meyer HE; Schwarte-Waldhoff I
    Proteomics; 2004 May; 4(5):1324-34. PubMed ID: 15188399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad4 deficiency in cervical carcinoma cells.
    Baldus SE; Schwarz E; Lohrey C; Zapatka M; Landsberg S; Hahn SA; Schmidt D; Dienes HP; Schmiegel WH; Schwarte-Waldhoff I
    Oncogene; 2005 Jan; 24(5):810-9. PubMed ID: 15531914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of secreted proteins of non-small cell lung cancer.
    Huang LJ; Chen SX; Luo WJ; Jiang HH; Zhang PF; Yi H
    Ai Zheng; 2006 Nov; 25(11):1361-7. PubMed ID: 17094902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differential proteomic analysis of human colorectal carcinoma cell lines SW620 and SW480 with different metastatic potentials].
    Qu LJ; Ding YQ; Liang L
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1211-5, 1220. PubMed ID: 16234091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of the tumorigenic phenotype by chromosome 18 transfer into pancreatic cancer cell lines.
    Lefter LP; Furukawa T; Sunamura M; Duda DG; Takeda K; Kotobuki N; Oshimura M; Matsuno S; Horii A
    Genes Chromosomes Cancer; 2002 Jun; 34(2):234-42. PubMed ID: 11979557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of Smad4 protein expression occurs infrequently in endometrial carcinomas.
    Liu FS; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC
    Int J Gynecol Pathol; 2003 Oct; 22(4):347-52. PubMed ID: 14501814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and identification of a 7.6-kDa protein in media conditioned by superinvasive cancer cells.
    Dowling P; Maurya P; Meleady P; Glynn SA; Dowd AJ; Henry M; Clynes M
    Anticancer Res; 2007; 27(3A):1309-17. PubMed ID: 17593624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential proteome analysis of colon carcinoma cell line SW480 after reconstitution of the tumour suppressor Smad4.
    Stühler K; Köper K; Pfeiffer K; Tagariello A; Souquet M; Schwarte-Waldhoff I; Hahn SA; Schmiegel W; Meyer HE
    Anal Bioanal Chem; 2006 Nov; 386(6):1603-12. PubMed ID: 17043799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
    Levy L; Hill CS
    Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of secreted proteins for the study of bladder cancer cell aggressiveness.
    Makridakis M; Roubelakis MG; Bitsika V; Dimuccio V; Samiotaki M; Kossida S; Panayotou G; Coleman J; Candiano G; Anagnou NP; Vlahou A
    J Proteome Res; 2010 Jun; 9(6):3243-59. PubMed ID: 20423150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
    Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
    J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad4 restoration leads to a suppression of Wnt/beta-catenin signaling activity and migration capacity in human colon carcinoma cells.
    Tian X; Du H; Fu X; Li K; Li A; Zhang Y
    Biochem Biophys Res Commun; 2009 Mar; 380(3):478-83. PubMed ID: 19284991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis reveals differences in protein expression in spheroid versus monolayer cultures of low-passage colon carcinoma cells.
    Gaedtke L; Thoenes L; Culmsee C; Mayer B; Wagner E
    J Proteome Res; 2007 Nov; 6(11):4111-8. PubMed ID: 17918984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein and mRNA characterization in human colorectal carcinoma cell lines with different metastatic potentials.
    Liang L; Qu L; Ding Y
    Cancer Invest; 2007 Sep; 25(6):427-34. PubMed ID: 17882654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequence of gastrin-releasing peptide receptor activation in a human colon cancer cell line: a proteomic approach.
    Ruginis T; Taglia L; Matusiak D; Lee BS; Benya RV
    J Proteome Res; 2006 Jun; 5(6):1460-8. PubMed ID: 16739997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.